Tenet to pay $1.4M to settle medically unnecessary implant suit

Dallas-based Tenet Healthcare and one of its hospitals in Palm Springs, Calif., will pay $1.41 million to resolve allegations that they knowingly charged Medicare for implanting unnecessary cardiac monitors in patients in violation of the False Claims Act, the U.S. Justice Department said.

Advertisement

The lawsuit claims that surgeons at Tenet’s Desert Regional Medical Center implanted unnecessary cardiac monitors in Medicare beneficiaries between 2014 and 2017. Medicare only reimburses services that are considered medically necessary.

“Invasive medical procedures, such as implanting heart monitors, are not without risk,” said Timothy DeFrancesca, special agent with the HHS Office of Inspector General.  “Therefore, when these procedures are medically unnecessary, as contended in this case, people in government health programs are put at needless peril, and taxpayers end up with the bill.”       

The settlement resolves the suit brought by whistleblower Michael Grace, a former Desert Regional Medical employee.

More articles on legal and regulatory issues:

Woman stabbed in Ascension garage sues, claims hospital was negligent
Texas university medical center investigates patient record mix-up
Sharing patient’s photo on social media is not illegal, Minnesota court rules

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.